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Abstract
Introduction: Prophylactic antimicrobial selection and administration for the prevention
of surgical site infections in vascular surgery is a recommended best practice. Nonadherence to published guidelines on the selection and administration of antimicrobials
has been observed and may lead to reduced efficacy of antimicrobial prophylaxis.
Methods: An observational, descriptive design was used to study clinician
knowledge and behavior and included a retrospective patient record review and
provider knowledge survey. A clinical education intervention targeting providers
responsible for the selection and administration of antimicrobial prophylaxis was
conducted. A repeat patient record review and knowledge survey was completed
following the education intervention.
Results: The rate of timely administration of all antimicrobials increased from 69.2% to
88.9% (χ2 = 0.5640, df = 1, p = 0.4526), and for vancomycin from 16.7% to 63.67% (χ2 =
5.3158. df = 1, p = 0.0241). Rate of appropriate selection increased from 76.9% to 83.8%
(χ2 = 0.5640, df = 1, p = 0.4526). Knowledge and confidence among clinicians improved
in some areas regarding the selection and administration of antimicrobial agents.
Conclusion: This quality assessment and process improvement study demonstrated that
with targeted educational experiences and supportive clinical decision-making tools,
clinicians responsible for vascular surgery patients can improve their knowledge,
selection and timely administration of prophylactic antimicrobials. Implementing these
processes into existing pre-operative patient screening/assessment clinics and surgery
scheduling mechanisms would hardwire this process setting the stage for clinical
outcome trials.
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Perioperative Antimicrobial Prophylaxis in Vascular Surgery:
A Quality Assessment and Improvement Project
Background
Surgical site infections (SSI), defined by the Centers for Disease Control and
Prevention (CDC) as “an infection that occurs after surgery in the area of the body where
the surgery took place…” (CDC, 2016), are the second most common type of healthcare
associated infection (Anderson et al., 2014; Culver, et al,1991). Approximately 140,000
vascular surgery procedures are performed annually in the United States (Calderwood et
al, 2014; AHRQ-HCUPnet, 2016). Risk factors for vascular SSIs may be patient related,
surgical (procedure) related, and/or environment related (Tatterton & HomerVanniasinkam, 2011). Patient factors that increase risk include: nasal colonization with
methicillin sensitive staphylococcus aureus (MSSA) or methicillin resistant
staphylococcus aureus (MRSA), end-stage renal disease, obesity, advanced age, smoking,
and diabetes (Inui & Bandyk, 2015). Environmental factors that augment risk include the
degree of operating room ventilation, environmental surface cleaning, surgical instrument
and implant sterility, surgical attire, and sterile operative technique (Inui & Bandyk,
2015). Vascular procedures that are open/infrainguinal (infra-aortic) and those with
prosthetic implantation are associated with the highest infection rates, and highest
morbidity, respectively (Tatterton & Homer-Vanniasinkam, 2011; Vogel, et al., 2010;
Stone, et al., 2010; Ryan, Calligaro, Scharff, & Dogherty, 2004).
Vascular surgery patients are at increased risk of developing surgery related
infections (Tatterton & Homer-Vanniasinkam, 2011). When compared to overall SSI
rates of 1-5%, reported by the Centers for Disease Control and Prevention’s National
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Nosocomial Infections Surveillance Risk Category System, vascular surgery patients
have SSI rates of 5-30% (Anderson et al., 2014; Calderwood et al, 2014; Culver, et al,
1991; NNIS, 2004; Tatterton & Homer-Vanniasinkam, 2011; Stone, et al., 2010). The
institutional standardized infection ration (SIR) for SSI occurrence for colon surgery
(95% CI [0.949, 1.947]) is no different than national benchmarks (SIR =1) (Medicare,
2019). For abdominal hysterectomy surgery institutional SIR for SSI occurrence (95% CI
[0.009, 0.863]) are better than national benchmarks (SIR = 1) (Medicare, 2019). These
are the only reported local SSI data by this institution. Local vascular surgery SSI rates
are not readily published or systematic surveilled, however some vascular surgery
attending physician receive a report on detected SSIs.
Patients who undergo vascular surgery have increased morbidity and mortality
when they develop an SSI, vascular prosthetic graft infection (VPGI), or vascular access
infections (Tatterton & Homer-Vanniasinkam, 2011). An increased risk of death
following SSI has been described, with a relative risk (RR) of 2.2, 95% CI [1.1, 4.5]
(Forbes & McLean, 2013). Mortality has been estimated as high as 13-58% when
associated with vascular prosthetic graft infections (Young, Washer, & Malani, 2008).
Antimicrobial therapy continues to be strongly recommended by the CDC,
National Surgical Infection Prevention Project, Surgical Infection Society and Society for
Healthcare Epidemiology of America (Page et al., 1993; Bratzler & Houck, 2004;
Tatterton & Homer-Vanniasinkam, 2011; Bratzler, et al., 2013; Hsu, 2014). Current best
practice includes the screening of patients preoperatively for the appropriate
antimicrobial prophylaxis. It is recommended that vascular surgery patients receive
weight-based cefazolin, a second-generation cephalosporin, unless the patient has a
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serious life-threatening allergic reaction to cephalosporins, is colonized with MRSA
and/or is scheduled to undergo an infra-aortic prosthetic implantation for which
vancomycin is recommended. Deviation from the current guidelines for the
administration of the appropriate preoperative prophylactic antimicrobial therapy has
been observed (Zaidi, Tariq, & Breslin, 2009; Hawn et al., 2008; Weber et al., 2008;
Dull, Baird, Dulac, & Fox, 2008; Tatterton & Homer-Vanniasinkam, 2011), does not
meet current best practice guidelines (Bratzler et al, 2013) and should be evaluated,
measured and improved upon.
Review of Literature
Databases utilized to identify pertinent literature included the Cumulative Index to
Nursing and Allied Health (CINAHL) complete, Ovid Medline, and PubMed Clinical
Queries. Keywords and Medical Subject Headings (MeSH) included: surgical wound
infection/*prevention & control, surgical wound infection/*microbiology, vascular
surgical procedures/*adverse effects, drug administration schedule, antibiotic
prophylaxis/*methods, anti-bacterial agents/*administration & dosage, anti-bacterial
agents/*therapeutic use, surgical wound infection/epidemiology, anti-bacterial
agents/*therapeutic use, vancomycin/*therapeutic use, vancomycin/administration and
dosage, and practice patterns. Practical screens were used to focus the review and
included publication dates of 2000-2017 and English language, peer reviewed articles.
Landmark articles were included despite publication date limiters when five or more
articles referenced the work, this totaled one landmark study by Classen (1992).
Methodological screens applied included national and international guidelines, systematic
review or meta-analyses of randomized controlled trials, randomized controlled trials,
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case control studies, cohort studies and descriptive and qualitative studies. Articles
selected for review were organized into patient / economic significance and scientific
underpinnings categories. A table summarizing the articles reviewed can be found in the
appendices (Appendix A)
Patient & Economic Significance
The impact of SSIs in the vascular surgery patient has a human cost as well as a
financial cost (de Lissovoy et al., 2009; Gagliardi, Fenech, Eskicioglu, Nathens, &
McLeod, 2009; Stone et al., 2010; Salkind & Rao, 2011; Dua et al., 2014). A patient who
develops an SSI, compared to a patient who does not, experiences increased pain,
undergoes secondary operations, spends an average of 17 days more hospitalized, has a
two-fold chance of mortality, and is five times more likely to be re-admitted to the
hospital (Tatterton & Homer-Vanniasinkam, 2011).
The financial cost associated with infections in vascular surgery patients can be
extrapolated from the above listed patient (human) costs and aggregate data on the cost of
SSIs across all surgical services. In 2014, the Society for Healthcare Epidemiology of
America reported the estimated annual cost associated with the development of an SSI
ranges from $3.5 billion to $10 billion (Anderson et al., 2014). While estimates directly
reflect the increased cost associated with vascular surgery patients, Engemann et al.
(2003) found that surgery patients with a MRSA SSI had an additional cost of $40,000
per hospital stay compared to those with MSSA SSIs.
Infection is the most common complication associated with vascular surgery
(Tatterton & Homer-Vanniasinkam, 2011). Clinicians caring for these patients have a
responsibility to design and implement systems based care models to meet guideline
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recommendations in an effort to maximize adherence to best practices (van der Slegt, et
al. 2013; Anderson et al., 2014; Waits et al., 2014; Sutherland, et al., 2014).
Scientific Underpinnings
Gram-positive microorganisms make up approximately 80% of vascular SSIs,
most commonly identified as staphylococcus aureus and coagulase-negative
staphylococci (Tatterton & Homer-Vanniasinkam, 2011). Gram-negative species are also
found, yet to a lesser degree (20%), and include Escherichia coli, Pseudomonas
aeruginosa, and Klebsiella pneumoniae (Tatterton & Homer-Vanniasinkam, 2011).
Cefazolin, a fourth-generation cephalosporin, continues to be the most recommended
antimicrobial agent, due to its gram-positive microbial coverage, low cost, with gram
negative coverage which includes Escherichia coli and Klebsiella pneumoniae (Bratzler
et al., 2013). When infrainguinal prosthetic implantation is anticipated in patients with
known MRSA colonization or in patients with a true cephalosporin allergy, antibiotics
such as vancomycin (a glycopeptide) or daptomycin (a cyclic lipopeptide) are
recommended to be added or used as an alternative, respectively (Bratzler et al., 2013).
These recommendations come from the 2013 American Society of Health-System
Pharmacists report on the clinical practice guidelines for antimicrobial prophylaxis in
surgery (Bratzler et al., 2013).
The efficacy of timely prophylactic antimicrobial administration was described in
a landmark report by Classen et al. (1992). This report prompted the adoption of
widespread guidelines for well-timed prophylactic use of antimicrobial agents to prevent
surgery associated infections. Since then, there have been numerous reports that correlate,
and a few that refute, the timing of antimicrobial agent administration to the occurrence
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of SSIs (Hawn, Itani, Gray, Vick, Henderson, & Houston, 2008; Weber et al, 2008;
Steinberg et al, 2009; Stone, et al., 2010; Fry, 2006; Anderson, et al, 2014; Dua et al,
2014; Stone et al, 2015).
The evidence that questions the importance of timing of administration is
marginal. Two reports by Hawn and colleagues (Hawn et al., 2008; Hawn et al., 2013)
challenge the importance of timing. However, methodological weaknesses can be
identified in these works. In these reports, when two antimicrobial agents were used, only
the one administered “closest to, but before incision” was recorded for timing of
antibiotic (Hawn et al., 2013, pg. 650). The limitation of this approach centers on the
selection for and reporting of an independent variable (timing of antibiotic) that excludes
the considerable circumstances where more than one agent was used, thus overestimating
the occurrence of timely administration. This is significant given that one agent can be
administered rapidly (e.g., cefazolin) and the other often requires up to 60-120 minutes to
be administered (e.g., vancomycin).
Despite any perceived controversy surrounding the timing of antimicrobial
administration, current guidelines continue to recommend their timely routine use in
high-risk procedures (Bratzler et al., 2013). However, despite these recommendations
reports conclude that the timely administration of antimicrobial prophylaxis occurs only
50-80% of the time (Hawn et al., 2008; Weber et al., 2008; Dull, et al., 2008; Tatterton &
Homer-Vanniasinkam, 2011), potentially resulting in sub-therapeutic antimicrobial tissue
concentrations. In patients at high risk for developing an SSI, such as those receiving
implanted graft material or with known MRSA colonization, low adherence to
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antimicrobial guidelines have been shown to increase the occurrence of SSI (Classen,
1992; Garey et al., 2006).
Purpose Statement
The purpose of this project was to conduct a systematic analysis of current
practice and improve upon the process of selection and timely administration of
vancomycin for antimicrobial prophylaxis in the adult vascular surgery population. Preintervention assessment will identify the current state of vancomycin selection and
administration and knowledge gaps among surgical and anesthesia clinicians caring for
vascular surgery patients. Process improvement interventions composed of clinical
education and decision support tools for clinicians who select (order) and administer the
antimicrobial agents were implemented following the initial assessment. The aim was to
improve adherence to established standards of practice and maximize the effectiveness of
preoperative antimicrobial prophylaxis. Specific study questions included:
(1) Will an educational program about recommended practice for the selection
and administration of prophylactic antimicrobial agents in vascular surgery
improve appropriate selection (agent and dosage) of antimicrobial
prophylaxis?
(2) Will an educational program about recommended practice for the selection
and administration of prophylactic antimicrobial agents in vascular surgery
improve timely administration (prior to surgical incision) of antimicrobial
prophylaxis?
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(3) Will an educational program about recommended practices for the selection
and administration of prophylactic antimicrobial agents in vascular surgery
improve clinician knowledge?
(4) Will an educational program about recommended practice for the selection
and administration of prophylactic antimicrobial agents in vascular surgery
improve clinician confidence?
Method
An observational, descriptive design was employed using retrospective record
review and pre-/post-intervention clinician knowledge survey. One-group pretest-posttest
and a two-group pretest-posttest methods were used to measure the knowledge, skill, and
attitudes of perioperative clinicians about the prevention of nosocomial infection before
and following the intervention. The one-group pretest-posttest data set was made up of a
subset of clinicians that were identical before and after the intervention, this group was
composed of the vascular surgery attending physicians and fellows. This subset is
ultimately responsible for the selection and ordering of prophylactic antimicrobial agents.
The two-group pretest-posttest data set was made up of all surgical and anesthesia
clinicians before and after the intervention, this was not an identical group of participants,
although there was some overlap.
The pretest-posttest clinician surveys were developed using key information from
the literature review. Survey questions were written to assess the knowledge of clinicians
required for determining the type and timing of prophylactic antimicrobial therapy in
vascular surgery patients and were derived from published guidelines (Page et al., 1993;
Bratzler & Houck, 2004; Tatterton & Homer-Vanniasinkam, 2011; Bratzler, et al., 2013;
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Hsu, 2014). Additional survey questions were written to assess clinician attitudes about
best practices and their confidence in adhering to them.
The effectiveness of this improvement process was assessed by comparing
guideline adherence rates before and after the interventions. A clinician education plan
was delivered using current best practice guidelines derived from the review of the
literature. This included a slide show presentation delivered to the vascular surgery team
during their grand rounds meeting (Appendix B). Anesthesiology personnel were
provided with the same information in a printed form accompanied with a one to one
tutorial in the perioperative setting. Learning objectives of the educational intervention
included understanding the importance of selection and administration timing of
antimicrobial prophylaxis as well as recognition of current barriers to adherence to best
practices. Secondary learning objectives included the incidence of surgical site infections
in vascular surgery, the microorganisms responsible for SSIs, as well as risk factors that
impact SSIs in vascular surgery. Throughout and for one month after the educational
intervention, dedicated time was spent in the perioperative environment with both
anesthesiology and surgical team members to support clinical decision making. In person
support was provided 2-3 days a week between September and November to reinforce the
educational program’s learning objectives.
Following the implementation of a curriculum aimed at improving peri-operative
clinician’s knowledge, skill, and attitudes about prescribing and administering
antimicrobial prophylactics in vascular surgery, repeat retrospective record review and
post-test surveys were performed. Variables of interest included the selection and
administration timing of vancomycin in patients with a history of penicillin allergy,
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incision prior to completed vancomycin administration, and planned infra-aortic
prosthetic graft implantation in a patient with known MRSA colonization. Timely
administration was determined by analyzing the time of initiation of each antimicrobial
administered compared to the time of surgical incision. Timely administration was
considered achieved when non-vancomycin agents were initiated five minutes prior to
incision, timely vancomycin administration was considered achieved if initiated 60min
prior to surgical incision. These variables were retrospectively evaluated in 76 cases of
antimicrobial administration, 39 prior to project implementation and 37 afterwards.
Setting/Population
Conducted at a mid-western United States tertiary academic urban hospital, this
study focused on patients scheduled for vascular surgery who were aged 18 years or
older. Clinicians whose practice was analyzed included attending vascular surgeons,
vascular surgery fellows, vascular surgery residents, general surgery residents, attending
anesthesiologist, nurse anesthetists, and anesthesiology residents.
Sample
Two separate samples were targeted by this project. A patient sample set and a
clinician sample set. The patient sample set was comprised of a convenience sample of
those scheduled for vascular surgery during periods of time during the months of
February 2018 and October 2018. Patients were excluded from evaluations if they were
less than 18 years old or if they did not receive antimicrobial prophylaxis. The patient
sample set was used to gain information about which antimicrobial agent was selected
and the timing of its administration in relation to surgical incision time.
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The clinician sample set was composed of clinicians with backgrounds in
anesthesiology and surgery. The clinician sample set was divided into two sub-groups
and underwent a one-group and two-group comparison (see Table 1). Due to the
unpredictable nature of clinician coverage and the variability of clinical assignments, it
was not possible to acquire a perfectly matched (identical) clinician sample. Inclusion
criteria for clinicians included the cadre of anesthesiology (attending anesthesiologists,
certified registered nurse anesthetists, and anesthesiology residents) and surgery
specialists (vascular surgery attending physicians, vascular surgery fellows, and vascular
surgery residents) that care for vascular surgery patients having various levels of
experience.
Table 1: Clinician Sample Breakdown

Clinician
Surgeon Attending
Surgeon Fellow
Surgeon Resident
Anesthesiologist
Attending
Nurse Anesthetist
(CRNA)
Anesthesiology Resident
Total

Two-Group
Clinician Sample
Pre
Post
Survey
Survey
n
n
6
6
4
4
9

4
4
6

7

7

2
n = 32

2
n = 29

One-Group*
Clinician Sample
Pre
Post
Survey
Survey
n
n
6
6
4
4

4
4

N = 14

*Indicates identical group of pre- & post- survey respondents. This group holds
primary responsibility for prophylactic antimicrobial medication ordering.

The one-group sub-set comparison was conducted on those with the role of
vascular surgeon. These individuals were made up of vascular surgery attending
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physicians, vascular surgery fellows, and vascular surgery residents. This group of
individuals have the primary responsibility of selection and ordering of surgical
antimicrobial prophylaxis. This group was identical in the pre and post evaluations, thus
permitting a one-group comparative analysis
A two-group comparison was completed for the entire pre- and post-intervention
survey clinician sample sets. This group was composed of a mix of same individuals and
unique individuals, necessitating a two-group analysis.
Data Collection
Collection of patient and case specific data (Appendix C) was conducted using
electronic medical record (EMR) review. During the course of this project there was an
institutional overhaul of the EMR systems, thus both MetaVision (iMDsoft 2018) and
EPIC© (EPIC systems corporation, Verona, WI, 2018) EMRs (post-intervention) were
utilized. A fifteen-question knowledge, skill, and attitude survey (Appendix D) were
utilized to query clinicians before and after the educational intervention. The surveys
were conducted face to face by a single researcher on an individual basis in the
perioperative areas. Post intervention surveys were performed approximately 2-3 weeks
after the educational series.
Data Analysis
Descriptive statistics, cross tabulation and Chi-square were used to describe the
observed characteristics in the subjects analyzed before and after the educational
intervention. Wilcoxon rank sum test was performed to assess test assumptions, for nonnormally distributed results, Wilcoxon signed rank analysis was performed. Statistical
significance was set at 0.05 for statistical difference.
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Results
Patient Sample Demographics: The pre-intervention patient sample (n = 39)
included individuals aged 38 to 90 years old compared to post-intervention patient
sample (n = 37) aged 19-78 years old. Age mean (m) and standard deviation (SD) for
both pre- and post- samples were m = 67.6 (SD = 12.4) and m = 59.4 (SD 14.0),
respectively.
Appropriate Antimicrobial Selection: In the pre-intervention patient sample
there were no incidences of true life threatening allergies to cephalosporins. In the postintervention patient sample, there were 4 cases of true life threatening cephalosporin
allergy, in three of these four cases (75%) vancomycin was selected.
There were no cases (pre or post) of patients with a history of MRSA positive
microbiological studies undergoing infra-aortic prosthetic graft implantation (another
indication for vancomycin).
Clinician selection of the appropriate antimicrobial agent was performed 30 out of
39 cases, a rate of 76.9%, in the pre-intervention patient sample compared to 31 out of 37
cases, a rate of 83.8%, in the post-intervention group (χ2 = 0.5640, df = 1, p = 0.4526).
Appropriate weight-based dosage of selected antimicrobial occurred at 35 out of 39
cases, a rate of 89.7%, in the pre-intervention group compared to 36 out of 37 cases, a
rate of 97.3%, in the post-intervention group (χ2 = 1.7654, df = 1, p = 0.1843). While not
statistically significant there is clinical significance in the selection of the proper
antimicrobial agent and dosage for any specific patient.
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Timely Administration of Antimicrobial: Administration of antimicrobials
(including vancomycin) prior to incision (i.e. timely administration) was achieved 27 out
of 39 times (69.2%) in the pre-intervention group compared to 32 out of 36 times
(88.9%) in the post-intervention group (χ2 = 4.3114, df = 1. p = 0.0379).
In the pre-intervention group, completed vancomycin administration occurred
prior to incision 2 out of the 12 times (16.7%) when vancomycin was selected for use. In
the post-intervention group, completed vancomycin administration occurred prior to
incision 7 out of the 11 times (63.6%) when vancomycin was selected for use. Chi square
analysis of these results (χ2 = 5.3158, df =1, p = 0.0241) suggests a statistically significant
improvement in the timely administration of vancomycin in the post-intervention group.
Clinician Knowledge: A subgroup analysis (one-group pre/post-test) was
performed using Wilcoxon signed rank test on those clinicians who currently have the
responsibility for ordering the antimicrobial prophylactic, namely the vascular surgery
attending physicians and their vascular surgery fellows. In one (Q6) of the three questions
targeting clinician knowledge (Q6*, S = -14.5, p = 0.0547) a difference approaching
statistical significance was noted. However when looking at all clinicians (two-group
analysis), two (Q4 & Q8) of the three questions demonstrated a significant improvement
in clinician knowledge following the intervention (Q4, χ2 = 4.1112, df =1, p = 0.0465;.
Q8, χ2 = 5.6509, df = 1, p = 0.0177). (see table 2).
Clinician Confidence: One survey question was designed to assess clinician
confidence in selecting the appropriate antimicrobial for surgical prophylaxis. Due to the
non-normal distribution that was observed between the pre- and post- intervention
surveys, non-parametric testing was performed. Chi square analysis applied to the entire
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pre- and post- survey groups (two-group pre/post-test) found statistically significant
differences in three specific questions. One such question targeted clinician confidence
(Q3, χ2 3.9936, df = 1, p = 0.0465), This question also demonstrated statistical
significance in the sub-group analysis, i.e. one-group pre/post, (χ2 = 3.8774, df = 1, p =
0.0325) (see Table 2).
Table 2
Q#

Survey Question

1

Antimicrobial prophylaxis for patients undergoing open vascular
surgery is consistent with best practice.
Antimicrobial prophylaxis does not contribute to reductions in
vascular surgical site infection.
I am confident in selecting the correct antimicrobial prophylaxis
for vascular surgery.
I am able to identify a serious adverse reaction to PCN or
cephalosporin.
I am able to identify whether or not a prosthetic graft will be
implanted prior to surgery.
I am able to identify whether or not a patient has a history of
MRSA/MSSA colonization.
I am able to identify whether or not a patient has increased risk
for MRSA/MSSA colonization.

2
3
4
5
6
7

Two-Group
(p-value)
0.2511

One-Group
(p-value)
1.0000

0.2718

0.1875

0.0465*

0.0325*

0.0501*

0.4375

0.8518

0.4375

0.1352

0.0547

0.2866

1.0000

8

The institution where I practice is considered to have a high
prevalence of MRSA/MSSA.

0.0177*

0.1563

9

It is best practice to administer the antimicrobial prophylaxis
prior to surgical incision.

0.8215

0.3750

10

Patients with known MRSA/MSSA colonization should always
receive vancomycin antimicrobial prophylaxis (if not allergic to
vancomycin).

0.6869

0.1484

11

Patients scheduled for infra-inguinal prosthetic graft implantation
should receive vancomycin antimicrobial prophylaxis (if not
allergic to vancomycin).

0.3654

0.4922

12

Patients with serious adverse reactions to
penicillin/cephalosporins should receive vancomycin
antimicrobial prophylaxis (if not allergic to vancomycin).

0.1505

0.1719

13

If a patient has serious allergic reactions to cephalosporins AND
vancomycin, I am confident in determining the best antimicrobial
prophylaxis for vascular surgery procedures.

0.0658

1.0000

14

Overall, our antimicrobial prophylaxis selection is adherent to
current clinical guidelines for vascular surgery.

0.7549

0.7500
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Survey Question
Overall, antimicrobial prophylaxis administration is adherent to
current clinical guidelines for vascular surgery.

Two-Group
(p-value)
0.0765

19
One-Group
(p-value)
0.3750

Discussion
Appropriate Antimicrobial Selection: Potential clinical significance was also
identified by the reduction of both inappropriately selected antimicrobial agent and
inappropriate weight-based dosage of selected antimicrobial agent.
Timely Administration of Antimicrobial: Findings from this quality/process
improvement study of a midwestern academic vascular surgery service division indicates
that there was a statistically significant reduction in inappropriately administered
vancomycin following a clinician education intervention.
Clinician Knowledge: Improvement in clinician knowledge was noted in their
identification of serious, life-threatening allergic reactions to penicillins/cephalosporins,
as well as, institutional MRSA/MSSA prevalence rates.
Clinician Confidence: Survey data suggest that among all clinicians surveyed
there was a statistically significant improvement in clinician confidence in selecting the
correct antimicrobial prophylactic for vascular surgery.
Limitations
Observing approximately 40 sequential pre- and post-intervention vascular
surgery cases provided 12 and 11 vancomycin cases respectively for analysis. This small
sample size lacks statistical power. Vancomycin was selected about 30% of the time
when an antimicrobial prophylactic agent was indicated. This rate was observed for both
pre- and post-intervention groups. This patient sample size was set by the time allocated
to perform data collection and an estimation of frequency of surgical cases to be
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evaluated. The frequency of vancomycin selection and administration was
underestimated. Clinician samples sets were not controlled for with exception of the
vascular surgeon subgroup, control of all clinician’s studies would have permitted onegroup parametric testing of all survey data.
Vancomycin is strongly indicated for vascular surgery patients in two instances
(true life-threatening cephalosporin allergy and infra-aortic prosthetic graft implantation
in patients with MRSA colonization). These two scenarios were not observed in both
sample sets (pre & post) thus impairing the ability of this study to report on the effects of
the intervention with respect to these two scenarios.
During the implementation of this quality assessment and improvement process
the medical center where the data was being collected underwent an overhaul of their
electronic health record systems. Due to this there were some differences in the manner
by which some data points were recorded and ultimately measured. Although no obvious
omissions or incorrect interpretations are suspected, they cannot be completely ruled out
due to the possibility of user error with the implementation of a new software application.
Local institutional baseline SSI data for vascular surgery was not available thus
only general assumptions about the state of SSI incidence in this specific population can
only be assumed by evidence from studies in this field.
This study was also vulnerable to the Hawthorne effect as clinician participants
were aware of the educational intervention they had participated in. To manage any
instrumental threats, the pre/post tests were identical. There are no obvious regression
threats as the population targeted is based on contact with the vascular surgery patient
population alone. The one-group test for clinician knowledge and confidence was also a
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small sample size, however was specific to the current paradigm for prescribing of preoperative antimicrobial prophylaxis (is the purview of this subgroup). Those outside of
this vascular surgery subset currently hold more of a supportive role on this variable.
Implications for Practice and Recommendations for Future Research
Practice implications identified by this project include the observed failure rate of
timely vancomycin administration, a failure rate that persists despite an effective
intervention. It is encouraging that a positive impact was observed, however there is still
great need for practice change to reduce or eliminate this ongoing failure of timely
administration of vancomycin. Also identified by the implementation of this project were
challenges in SSI surveillance in the vascular surgery population. How SSI surveillance
is routinely performed needs to further assessed, redesigned and implemented in an effort
to evaluate the efficacy of and degree of impact on patient centered outcome
interventions such as this clinical scholarship project.
The ability of education and clinical support tools to improve selection and timely
administration of pre-operative antimicrobial prophylactic agents was suggested by this
project. While the overall incidence of vancomycin selection did not change between
groups, there was a reduction in both the number of inappropriately selected agents
(vancomycin was selected less frequently) and inappropriately chosen doses of
vancomycin. This has the potential to enhance the clinical effectiveness of vancomycin
(when selected) to prevent a surgical site infection due to increased likelihood of
achieving levels above the minimal inhibitory plasma and tissue concentrations.
Furthermore, this process improvement study demonstrates that timely clinical
decision support resources, delivered at the point of decision-making, may improve
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processes to perpetuate appropriate clinician decision making. A key implication for
clinical practice is to hardwire this process, this is the likely next step for this project.
Specifically, to leverage pre-operative patient screening and surgery scheduling practices
to select and time the administration of pre-operative antimicrobial prophylaxis. The
overhaul of the electronic health record system at this institution creates the opportunity
to further develop screening tools that support clinicians in the selection and timely
administration of prophylactic antimicrobials.
Following further development and hardwiring of processes to support
prophylactic antimicrobial decision-making, future research should focus on the ability of
such process improvement activities to impact the patient centered outcomes i.e., rate of
surgical site infections. Potentially answering the following question “Can process
improvement strategies aimed at improving the selection and timely administration of
antimicrobial prophylaxis reduce surgical site infections in the vascular surgery
population?”.
Conclusions
This quality assessment and process improvement study demonstrated that with
targeted educational experiences and supportive clinical decision-making tools, clinicians
responsible for vascular surgery patients can improve their knowledge, confidence, and
ability to select and timely administer antimicrobial prophylactic agents. Routine SSI
surveillance is needed in this patient population prior to future outcome studies.
Implementing these processes into existing pre-operative patient screening/assessment
clinics and surgery scheduling mechanisms would hardwire this process setting the stage
for clinical outcome trials.

ANTIMICROBIAL PROPHYLAXIS IN VASCULAR SURGERY

23

References
Agency for Healthcare Research and Quality-Healthcare Cost and Utilization Project
(AHRQ-HCUPnet). (2016, September 20). Statistics on Hospital Stays. Retrieved
from http://hcupnet.ahrq.gov/
Anderson, D. J., Podgorny, K., Berríos-Torres, S. I., Bratzler, D. W., Dellinger, E. P.,
Greene, L., … Kaye, K. S. (2014). Strategies to Prevent Surgical Site Infections in
Acute Care Hospitals: 2014 Update. Infection Control & Hospital Epidemiology, 35,
S66-88. https://doi.org/10.1086/676022
Bratzler, D. W., Dellinger, E. P., Olsen, K. M., Perl, T. M., Auwaerter, P. G., Bolon, M.
K., … Weinstein, R. A. (2013). Clinical practice guidelines for antimicrobial
prophylaxis in surgery. American Journal Of Health-System Pharmacy: AJHP:
Official Journal Of The American Society Of Health-System Pharmacists, 70(3),
195–283. https://doi.org/10.2146/ajhp120568
Bratzler, D. W., & Houck, P. M. (2004). Antimicrobial prophylaxis for surgery: an
advisory statement from the National Surgical Infection Prevention Project. Clinical
Infectious Diseases: An Official Publication Of The Infectious Diseases Society Of
America, 38(12), 1706–1715.
Calderwood, M. S., Kleinman, K., Bratzler, D. W., Ma, A., Kaganov, R. E., Bruce, C. B.,
… Huang, S. S. (2014). Medicare claims can be used to identify US hospitals with
higher rates of surgical site infection following vascular surgery. Medical Care,
52(10), 918–925. https://doi.org/10.1097/MLR.0000000000000212
Centers for Disease Control and Prevention. (2016, September 15). Surgical Site Infection
(SSI). Retrieved from http://www.cdc.gov/hai/ssi/ssi.html

ANTIMICROBIAL PROPHYLAXIS IN VASCULAR SURGERY

24

Classen, D. C., Evans, R. S., Pestotnik, S. L., Horn, S. D., Menlove, R. L., & Burke, J. P.
(1992). The timing of prophylactic administration of antibiotics and the risk of
surgical-wound infection. The New England Journal Of Medicine, 326(5), 281–286.
Culver, D. H., Horan, T. C., Gaynes, R. P., Martone, W. J., Jarvis, W. R., Emori, T. G.,
… et. al. (1991). Surgical wound infection rates by wound class, operative
procedure, and patient risk index. National Nosocomial Infections Surveillance
System. The American Journal Of Medicine, 91(3B), 152S–157S.
de Lissovoy, G., Fraeman, K., Hutchins, V., Murphy, D., Song, D., & Vaughn, B. B.
(2009). Surgical site infection: incidence and impact on hospital utilization and
treatment costs. American Journal Of Infection Control, 37(5), 387–397.
https://doi.org/10.1016/j.ajic.2008.12.010
Dua, A., Desai, S. S., Seabrook, G. R., Brown, K. R., Lewis, B. D., Rossi, P. J., … Lee,
C. J. (2014). The effect of Surgical Care Improvement Project measures on national
trends on surgical site infections in open vascular procedures. Journal Of Vascular
Surgery, 60(6), 1635–1639. https://doi.org/10.1016/j.jvs.2014.08.072
Dull, D., Baird, S. K., Dulac, J., & Fox, L. (2008). Improving prophylactic perioperative
antibiotic utilization in a hospital system. Journal For Healthcare Quality: Official
Publication Of The National Association For Healthcare Quality, 30(6), 48–56.
Engemann, J. J., Carmeli, Y., Cosgrove, S. E., Fowler, V. G., Bronstein, M. Z., Trivette,
S. L., … Kaye, K. S. (2003). Adverse clinical and economic outcomes attributable to
methicillin resistance among patients with Staphylococcus aureus surgical site
infection. Clinical Infectious Diseases: An Official Publication Of The Infectious
Diseases Society Of America, 36(5), 592–598.

ANTIMICROBIAL PROPHYLAXIS IN VASCULAR SURGERY

25

Forbes, S. S., & McLean, R. F. (2013). Review article: the anesthesiologist’s role in the
prevention of surgical site infections. Canadian Journal Of Anaesthesia = Journal
Canadien D’anesthésie, 60(2), 176–183. https://doi.org/10.1007/s12630-012-9858-6
Fry, D. (2006). The surgical infection prevention project: processes, outcomes, and future
impact. Surgical Infections, 7(supplement 3), S17–S26.
Gagliardi, A. R., Fenech, D., Eskicioglu, C., Nathens, A. B., & McLeod, R. (2009).
Factors influencing antibiotic prophylaxis for surgical site infection prevention in
general surgery: a review of the literature. Canadian Journal Of Surgery. Journal
Canadien De Chirurgie, 52(6), 481–489.
Garey, K. W., Dao, T., Chen, H., Amrutkar, P., Kumar, N., Reiter, M., & Gentry, L. O.
(2006). Timing of vancomycin prophylaxis for cardiac surgery patients and the risk
of surgical site infections. The Journal Of Antimicrobial Chemotherapy, 58(3), 645–
650.
Hawn, M. T., Itani, K. M., Gray, S. H., Vick, C. C., Henderson, W., & Houston, T. K.
(2008). Association of Timely Administration of Prophylactic Antibiotics for Major
Surgical Procedures and Surgical Site Infection. Journal of the American College of
Surgeons, 206(5), 814–819. https://doi.org/10.1016/j.jamcollsurg.2007.12.013
Hawn, M. T., Richman, J. S., Vick, C. C., Deierhoi, R. J., Graham, L. A., Henderson, W.
G., & Itani, K. M. F. (2013). Timing of surgical antibiotic prophylaxis and the risk of
surgical site infection. JAMA Surgery, 148(7), 649–657.
https://doi.org/10.1001/jamasurg.2013.134
Hsu, V. (2014). Prevention of health care-associated infections. American Family
Physician, 90(6), 377–382.

ANTIMICROBIAL PROPHYLAXIS IN VASCULAR SURGERY

26

Inui, T., & Bandyk, D. F. (2015). Vascular surgical site infection: risk factors and
preventive measures. Seminars In Vascular Surgery, 28(3–4), 201–207.
https://doi.org/10.1053/j.semvascsurg.2016.02.002
Medicare. (2019). Hospital compare hospital profile: Barnes Jewish Hospital. Retrieved
from
https://www.medicare.gov/hospitalcompare/profile.html#vwgrph=1&profTab=3&ID
=260032&loc=63110&lat=38.6212468&lng=90.2526163&name=BARNES%20JEWISH%20HOSPITAL&Distn=1.5
National Nosocomial Infections Surveillance (NNIS) System Report, data summary from
January 1992 through June 2004, issued October 2004. (2004). American Journal Of
Infection Control, 32(8), 470–485.
Page, C. P., Bohnen, J. M., Fletcher, J. R., McManus, A. T., Solomkin, J. S., &
Wittmann, D. H. (1993). Antimicrobial prophylaxis for surgical wounds. Guidelines
for clinical care. Archives Of Surgery (Chicago, Ill.: 1960), 128(1), 79–88.
Ryan, S. V., Calligaro, K. D., Scharff, J., & Dougherty, M. J. (2004). Management of
infected prosthetic dialysis arteriovenous grafts. Journal of Vascular Surgery, 39(1),
73–78.
Salkind, A. R., & Rao, K. C. (2011). Antibiotic prophylaxis to prevent surgical site
infections. American Family Physician, 83(5), 585–590.
Steinberg, J. P., Braun, B. I., Hellinger, W. C., Kusek, L., Bozikis, M. R., Bush, A. J., …
Kritchevsky, S. B. (2009). Timing of antimicrobial prophylaxis and the risk of
surgical site infections: results from the Trial to Reduce Antimicrobial Prophylaxis

ANTIMICROBIAL PROPHYLAXIS IN VASCULAR SURGERY

27

Errors. Annals Of Surgery, 250(1), 10–16.
https://doi.org/10.1097/SLA.0b013e3181ad5fca
Stone, P., Campbell, J., AbuRahma, A., Safley, L., Emmett, M., & Asmita, M. (2010).
Vascular surgical antibiotic prophylaxis study (VSAPS). Vascular And
Endovascular Surgery, 44(7), 521–528. https://doi.org/10.1177/1538574410373837
Stone, P. A., AbuRahma, A. F., Campbell, J. R., Hass, S. M., Mousa, A. Y.,
Nanjundappa, A., … Emmett, M. (2015). Prospective randomized double-blinded
trial comparing 2 anti-MRSA agents with supplemental coverage of Cefazolin before
lower extremity revascularization. Annals Of Surgery, 262(3), 495–501.
https://doi.org/10.1097/SLA.0000000000001433
Sutherland, T., Beloff, J., Lightowler, M., Liu, X., Nascimben, L., & Urman, R. D.
(2014). Process measures to improve perioperative prophylactic antibiotic
compliance: quality and financial implications. The Health Care Manager, 33(4),
289–296. https://doi.org/10.1097/HCM.0000000000000027
Tatterton, M. R., & Homer-Vanniasinkam, S. (2011). Infections in vascular surgery.
Injury, 42 Suppl 5, S35–S41. https://doi.org/10.1016/S0020-1383(11)70131-0
van der Slegt, J., van der Laan, L., Veen, E. J., Hendriks, Y., Romme, J., & Kluytmans, J.
(2013). Implementation of a bundle of care to reduce surgical site infections in
patients undergoing vascular surgery. Plos One, 8(8), e71566–e71566.
https://doi.org/10.1371/journal.pone.0071566
Vogel, T. R., Dombrovskiy, V. Y., Carson, J. L., Haser, P. B., Lowry, S. F., & Graham,
A. M. (2010). Infectious complications after elective vascular surgical procedures.

ANTIMICROBIAL PROPHYLAXIS IN VASCULAR SURGERY

28

Journal Of Vascular Surgery, 51(1), 122–129.
https://doi.org/10.1016/j.jvs.2009.08.006
Waits, S. A., Fritze, D., Banerjee, M., Zhang, W., Kubus, J., Englesbe, M. J., … Hendren,
S. (2014). Developing an argument for bundled interventions to reduce surgical site
infection in colorectal surgery. Surgery, 155(4), 602–606.
https://doi.org/10.1016/j.surg.2013.12.004
Weber, W. P., Marti, W. R., Zwahlen, M., Misteli, H., Rosenthal, R., Reck, S., …
Widmer, A. F. (2008). The timing of surgical antimicrobial prophylaxis. Annals Of
Surgery, 247(6), 918–926. https://doi.org/10.1097/SLA.0b013e31816c3fe
Young MH, Washer L, & Malani PN. (2008). Surgical site infections in older adults :
epidemiology and management strategies. Drugs & Aging, 25(5), 399–414.
Zaidi, N., Tariq, M., & Breslin, D. (2009). Perioperative use of antibiotics in elective
surgical patients: timing of administration. Journal Of Perioperative Practice, 19(7),
225–227.

ANTIMICROBIAL PROPHYLAXIS IN VASCULAR SURGERY

Appendices

29

30

Appendix A
Evidence Table
#

First Author

Year

Level of
Evidence

Sample
Composition

Results

Limitations

1

Classen

1992

II*

2847 patients

Randomized
controlled Trial

Single center

0.6% SSI rate in those
who received
antimicrobial
preoperatively

Exclusion of
patients admitted
>48hr prior to
surgery (an
important subset)

Across all lines of
surgical services

3.3% SSI rate in those
who received
antimicrobial
postoperatively

Single center

Those who received
antimicrobial 1-2hrs prior
to surgery had fewer
(P<0.001) SSIs
2

Engemann

2003

IV*
Cohort Study

Patients
undergoing
surgery with SSI
surveillance
N = 479
Control group

MRSA resistance is
Different types of
independently associated antimicrobial
with increased mortality therapy was not
examined.
MRSA resistance is
independently associated Possible
with hospital expense /
underestimation of
charges
cost due to
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#

First Author

Year

Level of
Evidence

Sample
Composition

31

Results

MRSA group
MSSA group

3

Fry

2006

V*
Retrospective
analysis
Randomized

potential for
outpatient
treatment not
captured

Multi center
(national CMS SIP
database)

Poor compliance with
timely administration,
56% compliance

Detailed patient
population not
reported

788 randomly
selected cases to
establish baseline

Good performance on
antimicrobial selection,
97% correctly selected

Retrospective
Variable data
reporting accuracy
across clinical sites
(i..e database
metrics)

Poor compliance with
discontinuing therapy
<24hrs, 41% compliant
4

Garey

2006

Limitations

III*
Patients
Prospective non- undergoing
randomized
coronary bypass
grafting or valve
replacement
surgery 06/200206/2005.

SSI rates were lowest in
those receiving
vancomycin between 1660min before surgical
incision compared to the
other four time
groupings (3.4% vs.
26.7%, 7.7%, 6.9%, and

Single center
Non-randomized
No control group
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#

First Author

Year

Level of
Evidence

32

Sample
Composition

Results

Five groups
assigned based on
timing of
vancomycin
dosing prior to
surgical incision
N = 2048

7.8%)

Limitations

68% male, 53%
Caucasian.
5

Dull

2008

QA/QI report
Exemplar of
successful
implementation

6

Hawn

2008

IV*
retrospect
cohort

SCIP adherence at
2 acute care
hospitals in MI

SCIP 1 = 64% to 90%
SCIP 2 = 95% to 93%
SCIP 3 = 60% to 95%

Not scientific
SCIP has fallen out
of favor

General trend toward
improved adherence
VA-elective
Procedures

Timely admin occurred
86.4%

Not all vascular
surgery patients.

N=9,195

Untimely SSI = OR 1.29,
95%CI 0.99, 1.67

VA pop. not
representative (not
generalizable)

Mostly male
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#

First Author

Year

Level of
Evidence

Sample
Composition

33

Results

Limitations

NSQIP used for
outcome (limited to
NSQIP collected
information)
7

Weber

2008

IV*
Prospect
Observe
cohort

Consecutive
enrollment of
visceral,
Vascular, and
Trauma sx
01/2000-12/2001
3836 cases
50.7% male
49.3% female

49% of the time antiBiotic was admin
Within the final 30min
prior to incision
Increased odds of SSI if
Antibiotic admin <30 min
prior.
OR 1.95; 95%CI 1.4-2.8

Not RCT
Post-discharge
Monitoring not
standardized
Optimal timing not
generalizable to all
Antibiotic agents

Admin 59-30min prior to
incision is more effective
than during last 30min

15.3% vasc cases
8

De Lissovoy

2009

IV*
Retrospective
analysis

Data from 1054
hospitals in 37
states (accounting
for ~90% of US

Average increase in cost
associated with SSI =
$20,842

Use of
administrative data
can be imprecise.
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#

First Author

Year

Level of
Evidence

Sample
Composition

Results

hospital
discharges)

406,730 additional
hospital days ($900
million when
extrapolated.

Surgical Subsets:
Neuro,
cardiovascular,
colorectal, GI,
OB/GYN, Ortho

9

Gagliardi

2009

Scoping Review
of the Literature

34

19 of 192 studies
reviewed
MEDLINE
COCHRANE
1996-2007
7 = antibx use
12 = adherence

Limitations

91,613 readmissions
leading to additional
521,933 days of care
($700 million when
extrapolated)
Factors that influence
practice:
-individual knowledge,
Attitudes, beliefs &
practices, institutional
support

Limited data (not
comprehensive)

Favor multi-disciplinary
pathways, computerized
order sets, and
individualized
performance data for QI
strategies

Not delineated by
type of surgery

Not scientific,
although very
systematic

No control (case
control) for
intervention (no
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#

First Author

Year

Level of
Evidence

Sample
Composition

35

Results

Limitations

matching by patient
or type of surgery)
10

Steinburg

2009

IV*
Prospective
Cohort,
multi-center

4472 surgical
Cases
29 hospitals
Cardiac
hip/knee
TAH

Surgical site Infection risk Not statistically
increased as the time
significant (p = 0.04)
interval between dose
and incision increased
Clinically significant
OR 1.74, 95%CI 0.983.04

Limited statistical
power 2/2 low
number of (+) cases.
Post-discharge
surveillance not
standardized
Truncated follow-up
(due to parent
study)...under
ascertainment
(lowered power)
Vanco observations
too low.
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#

First Author

Year

Level of
Evidence

Sample
Composition

Results

Limitations

11

Patrick

2010

II*

18yo or >

66% power

Prospective
RCT

Vascular surgery

Adding anti-MRSA
prophylaxis does not
Reduce the incidence of
MRSA infection in lowrisk patients
Groin procedures were
3x as likely to acquire
infection (p = .0282)

Dressing
use/removal not
standardized

Groin procedures were
associated with longer
surgical times and higher
intraoperative glucose (p
= .0007)

High-risk patients
Excluded

Review of evidence for
timing of antibx therapy,
when to discontinue use,
and published guidelines
(SCIP measures)

SCIP is falling out of
favor

N = 169

No standardized
skin
decontamination

Single center

12

Salkind

2011

Review Article

5 articles with
class A evidence
(Timing)
4 articles with
class B evidence
(consistent with
guidelines/discont
inued within 24hrs

Limited amount of
identified evidence
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#

First Author

Year

Level of
Evidence

13

Tatterton

2011

Review Article

14

Bratzler

2013

Clinical Practice
Guidelines
American
Society of
Health-Care
Pharmacists

Sample
Composition

Multiorganizational
collaborative
panel of experts
Primary literature
published
between 19992010 via
MEDLINE,
EMBASE, and
Cochrane
Database of
Systematic
Reviews.

37

Results

Limitations

Review of evidence and
reports to describe the
incidence and type of
infections that occur in
the vascular surgery
population

Not scientific

Graded recommendation Limitation of
based on strength of
available literature
evidence (I-VII)
on antimicrobial
prophylaxis
Stratification between
different surgical
Difficulty in
procedures, i.e. specific
establishing
recommendations for
significant
specific types of surgery differences in
efficacy among
antimicrobial
agents.

ANTIMICROBIAL PROPHYLAXIS IN VASCULAR SURGERY

38

#

First Author

Year

Level of
Evidence

Sample
Composition

Results

Limitations

14

Hawn

2013

IV*
Retrospective
Cohort study

32,459 cases

Higher SSI rates w/
administration >60min
prior to incision
(OR 1.34, 95%CI 1.081.66)

Mostly male
patients

Orhtopedic
Colorectal
Vascular
Gynecologic
VA patient
population

16

Van der Slegt

2013

IV*
Prospective
Quasi
experimental
Cohort study

Significant relationship
between timing and SSI
(p = .003)

720 vascular cases Bundle implementation
Continuous
sample (3/20091/2010)

Bundle compliance from
10% to 80%
Use of bundle reduced
SSI (33% reduction)

Not capture of
intraoperative
redosing
Small group of nontimely
administration
Lack of direct causal
relationship (no
randomized control)
No performance of
interrupted time
series analysis
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#

First Author

Year

Level of
Evidence

Sample
Composition

Results

Limitations

17

Anderson

2014

I*
Systematic
Review

Practice
Recommendation

(relevant): administer
antibx prophylaxis
according to EB
standards and guidelines
(LEVEL I)

Not vascular specific

Administer with 1hr (2
hours allowed for vanc
and flouroquinolones)
Society for
Healthcare
Epidemiology of
America

Administer prior to
tournequet
Vanco 15mg/kg

Infectious Disease
Society of America
18

Dua

2014

VI*
Retrospective
analysis

National Inpatient
Sample (NIS)largest all-payer
inpatient
database
Stratified 20%

No improvement in rate
of SSI when SCIP
measures implemented
Increase in SSI rate with
open AAAs

Retrospective
design
Use of national
database compiled
by ICD-9 codes
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#

First Author

Year

Level of
Evidence

40

Sample
Composition

Results

Limitations

random sample of
all nonfederal
inpatient
admissions

Use of SCIP measures
may not be achieving
what was intended with
prophylactic
antimicrobial dosing

Only analyzed
inpatients, no long
term follow up data,
potentially
underreporting SSI
rates.

Descriptive report on
implementation of
methods to surveil and
adhere to SCIP inf 1,2,3
in a large academic
institution

Not scientific

2000-2010
Stratified by ICD-9
classification
19

Sutherland

2014

Process
Improvement

Measure to
improve SCIP
compliance
Descriptive

No other limitations

Single center
Hundreds of thousands
of dollars in cost savings
20

Waits

2014

IV*
Retrospective
Cohort study

Data from 24
hospitals in MI

Multisite sampling (more
generalizable than
previous similar studies)

4,085 colorectal
surgeries analyzed Large sample size
between 2008-

Difficulty in
inclusion of
urgent/emergent
surgeries
(numerous
incidents) may have
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#

21

First Author

Stone

Year

2015

Level of
Evidence

II*
Prospective
double-blind
randomized
controlled trial

41

Sample
Composition

Results

2011.

Single surgical population led to selection bias
(with exception)
Baseline education
of clinicians not
assessed

Adults undergoing Randomization
groin or lower
extremity vascular Use of Cohen’s delta
procedure
coefficient 3, due to
impaired adequacy of
N = 200
endpoint SSI evaluation
in both groups

Limitations

Single center
No multivariate
analysis to assess
confounders

*Melnyk Levels of Evidence: Melnyk, B.M. & Fineout-Overholt, E. (2015) Evidence-based practice in nursing & healthcare: A guide to best
practice (3rd ed.). Philadelphia, PA : Wolters Kluwer Health
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Education Tool
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Appendix C
Data Collection Tool
Date:
DOS:

Patient Weight (Kg):
BMI:
Surgery:

Patient Age:

YES

NO

ESRD
Hemodialysis
Peritoneal Dialysis

DM1
DM2
Smoking History

HgA1C:
HgA1C:
Pack year:

Serious PCN/Cephalosporin Allergy
Planned Infra-aortic graft implantation
Known MRSA colonization
Known MSSA colonization
Antibiotic Vancomycin
Antibiotic Cefazolin
Antibiotic Other
Antibiotic Start Time
Antibiotic Completed Time
Pre-Incision “time-out” Time
Surgical Incision Time
Time from Antibiotic Complete to Skin Incision

Rxn:

Type:
________:_________
________:_________
________:_________
________:_________
Min:
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Incision Prior to Completed Antibiotic Admin.
Appropriately Selected Antibiotic
Appropriately Administered Antibiotic
Appropriate Weight Based Antibiotic Dosage
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Appendix D
Vascular Surgery Clinical Practice Questionnaire
Date:____________________________
Clinician Role:__________________________

1. Antimicrobial prophylaxis for patients
undergoing open vascular surgery is
consistent with best practice.
2. Antimicrobial prophylaxis does not
contribute to reductions in vascular surgical
site infection.
3. I am confident in selecting the correct
antimicrobial prophylaxis for vascular
surgery.
4. I am able to identify a serious adverse
reaction to PCN or cephalorsporin.
5. I am able to identify whether or not a
prosthetic graft will be implanted prior to
surgery.
6. I am able to identify whether or not a
patient has a history of MRSA/MSSA
colonization.

Disagree

Neither
Disagree
or Agree

Agree

Strongly
Agree

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

1

2

3

4

5

Strongly
Disagree
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7. I am able to identify whether or not a
patient has increase risk for MRSA/MSSA
colonization.
8. The institution where I practice is
considered to have a high prevalence of
MRSA/MSSA.
9. It is best practice to administer the
antimicrobial prophylaxis prior to surgical
incision.
10. Patients with known MRSA/MSSA
colonization should always receive
vancomycin antimicrobial prophylaxis (if
not allergic to vancomycin)
11. Patients scheduled for infra-inguinal
prosthetic graft implantation should
receive vancomycin antimicrobial
prophylaxis (if not allergic to vancomycin).
12. Patients with serious adverse reactions to
penicillin/cephalosporins should receive
vancomycin antimicrobial prophylaxis (if
not allergic to vancomycin).

47

Disagree

Neither
Disagree
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ANTIMICROBIAL PROPHYLAXIS IN VASCULAR SURGERY

13. If a patient has serious allergic reactions to
cephalosporins AND vancomycin, I am
confident in determining the best
antimicrobial prophylaxis for vascular
surgery procedures.
14. Overall, our antimicrobial prophylaxis
selection is adherent to current clinical
guidelines for vascular surgery.
15. Overall, antimicrobial prophylaxis
administration is adherent to current
clinical guidelines for vascular surgery.
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